Use of the drug Prostatex plus in patients with chronic abacterial prostatitis and BPH
- Autores: Neymark A.I.1, Nozdrachev N.A.1, Kulchavenya E.V.2, Kholtobin D.P.1, Davydov A.V.1, Neymark A.B.1, Kovaleva Y.S.1, Yakovlev A.V.1
-
Afiliações:
- Altai State Medical University of the Ministry of Health of Russia
- FGBOU VO Novosibirsk State Medical University of Ministry of Health of Russia
- Edição: Nº 2 (2024)
- Páginas: 41-46
- Seção: Original Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/633552
- DOI: https://doi.org/10.18565/urology.2024.2.41-46
- ID: 633552
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Aim. To evaluate the efficiency of therapy with Prostatex plus rectal suppositories in the treatment of patients with chronic abacterial prostatitis and benign prostatic hyperplasia (BPH).
Materials and methods. A total of 50 men with chronic abacterial prostatitis of category III A, occurring in combination with BPH, were included in the study. All patients received Prostatex plus (rectal suppositories) 1 suppository 1 time per day. The duration of treatment was 20 days. After taking the drug, patients were followed-up for 40 days. There were three follow-up visits during the study period (days 1, 20 and 60).
Results. The study proved that the use of Prostatex plus rectal suppositories has a positive effect on urinary parameters, subjective and objective symptoms of chronic abacterial prostatitis and BPH, which allowed to recommend it for this group of patients, according to the following scheme: 1 suppository 1 time per day for 20 days.
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
A. Neymark
Altai State Medical University of the Ministry of Health of Russia
Autor responsável pela correspondência
Email: urologagmu@mail.ru
Ph.D., MD, professor, Head of the Department of Urology and Andrology with a course of Specialized Surgery
Rússia, BarnaulN. Nozdrachev
Altai State Medical University of the Ministry of Health of Russia
Email: nozdrachevuro@mail.ru
Ph.D., associate professor at the Department of Urology and Andrology with a course of Specialized Surgery
Rússia, BarnaulE. Kulchavenya
FGBOU VO Novosibirsk State Medical University of Ministry of Health of Russia
Email: urotub@yandex.ru
Ph.D., MD, professor, professor at the Department of Phthisiopulmonology
Rússia, NovosibirskD. Kholtobin
Altai State Medical University of the Ministry of Health of Russia
Email: urologagmu@mail.ru
Ph.D., MD, professor, professor at the Department of Urology and Andrology with a course of Specialized Surgery
Rússia, BarnaulA. Davydov
Altai State Medical University of the Ministry of Health of Russia
Email: andre1763@mail.ru
Ph.D., MD, associate professor, professor at the Department of Urology and Andrology with a course of Specialized Surgery
Rússia, BarnaulA. Neymark
Altai State Medical University of the Ministry of Health of Russia
Email: urologagmu@mail.ru
student
Rússia, BarnaulYu. Kovaleva
Altai State Medical University of the Ministry of Health of Russia
Email: k-derm@asmu.ru
Ph.D., MD, associate professor, Head of the Department of Dermatology and Venerology, Cosmetology and Immunology
Rússia, BarnaulA. Yakovlev
Altai State Medical University of the Ministry of Health of Russia
Email: urologagmu@mail.ru
Ph.D., associate professor, assistant at the Department of Urology and Andrology with a course of Specialized Surgery
Rússia, BarnaulBibliografia
- Lopatkin N.A. (ed.). Benign prostatic hyperplasia.-M., 1999; 216. Russian (Лопаткин Н.А.(ред.). Доброкачественная гиперплазия предстательной железы.-М., 1999; 216).
- Tkachuk V.N., Al-Shukri S.H., Lukyanov A.E. Medical treatment of patients with benign prostatic hyperplasia. St. Petersburg, 2000; 104. Russian (Ткачук В.Н., Аль-Шукри С.Х., Лукьянов А.Э. Медикаментозное лечение больных доброкачественной гиперплазией предстательной железы. СПб., 2000; 104).
- Tkachuk V.N., Al-Shukri S.H., Lotzan-Medvedev A.K. Evaluation of the effectiveness of vitaprost in patients with chronic abacterial prostatitis. Urology. 2006;2:71–75. Russian (Ткачук В.Н., Аль-Шукри С.Х., Лотцан-Медведев А.К. Оценка эффективности витапроста у больных хроническим абактериальным простатитом. Урология. 2006;2:71–75).
- Al-Shukri S.H., Gorbachev A.G., Tkachuk V.N. Our experience in the use of prostatilene in urology. Urology. 2003;6:32–36. Russian (Аль-Шукри С.Х., Горбачев А.Г., Ткачук В.Н. Наш опыт применения простатилена в урологии. Урология. 2003;6:32–36).
- Al-Shukri S.H., Gorbachev A.G., Borovets S.Yu., etc. Treatment of patients with prostate adenoma with prostatilen. Urology. 2006;6:22–26. Russian (Аль-Шукри С.Х., Горбачев А.Г., Боровец С.Ю. и др. Лечение больных аденомой предстательной железы простатиленом. Урология. 2006;6:22–26).
- Kamalov A.A., Efremov E.A., Dorofeev S.D. and others. Vitaprost-forte in the treatment of patients with prostate adenoma. Urology. 2007;3:39–47. Russian (Камалов А.А., Ефремов Е.А., Дорофеев С.Д. и др. Витапрост-форте в лечении больных с аденомой предстательной железы. Урология. 2007;3:39–47).
- Pushkar D.Yu., Rasner P.I. Symptoms of the lower urinary tract and benign prostatic hyperplasia. Urology 2006;3(adj.):4–18. Russian (Пушкарь Д.Ю., Раснер П.И. Симптомы нижних мочевыводящих путей и доброкачественная гиперплазия предстательной железы. Урология 2006;3(прил.):4–18).
- Emberton M., Fitzpatrick J.M., Garcia-Losa M., Qizilbash N., Djavan B. Progression of benign prostatic hyperplasia: systematic review of the placebo arms of clinical trials. BJU Int. 2008;102:981–986.
- Management of Non-neurogenic Male LUTS. European Association of Urology Guidelines. http://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/
- Management of Benign Prostatic Hyperplasia. American Urological Association Guidelines. https://www.auanet.org/benign-prostatic-hyperplasia-(2010-reviewed-and-validity-confirmed2014)
- https://www.vidal.ru/drugs/prostateks-plyus
- https://uroweb.ru/article/hronicheskiy-abakterialniy-prostatit-noviy-podhod-k-ponimaniyu-patogeneza-i-lecheniya
- kr6-dobrokachestvennaya-giperplaziya-predstatelnoj-zhelezy.pdf
- Neymark A.I., Neymark B.A., Nozdrachev N.A., Kondratieva Y.S., Borisen-ko D.V., Arkhipov D.O., Makarova A.A., Oberemok P.A. The use of Afalaza in the treatment of patients with chronic pelvic pain syndrome. Urology 2018;1:106–111. Russian (Неймарк А.И., Неймарк Б.А., Ноздрачев Н.А., Кондратьева Ю.С., Борисенко Д.В., Архипов Д.О., Макарова А.А., Оберемок П.А. Применение препарата Афалаза в лечении больных с синдромом хронической тазовой боли. Урология 2018;1:106–111).
Arquivos suplementares
![](/img/style/loading.gif)